Vol. 3 No. 7A (2022): The Effects of Tenofovir, Lamivudine, Dolutegravir (TLD) and Non-TLD on the Viral Load, Weight, and Body Mass Index of People Living with HIV Newly Initiating Antiretroviral Therapy in Cambodia
Student’s Abstract
The Effects of Tenofovir, Lamivudine, Dolutegravir (TLD) and Non-TLD on the Viral Load, Weight, and Body Mass Index of People Living with HIV Newly Initiating Antiretroviral Therapy in Cambodia
Narom Prak*1,2, Sodara Chan1, Yom An1
1- School of Public Health, National Institute of Public Health, Cambodia
2- National Center for HIV/AIDS, Dermatology and STIs (NCHADS)
*Corresponding author: Narom Prak, Email: praknarom3@gmail.com